Results 1 to 10 of about 330,644 (408)
Pressure, Flow Rate and Operating Speed Characteristics of a Continuous Flow Left Ventricular Assist Device During Varying Speed Support [PDF]
IEEE Access, 2020Hydraulic performance of Continuous Flow Left Ventricular Assist Devices depends on their pressure head and flow rate relations. Hydraulic characteristics of these devices are expressed by pressure head and flow rate loops in a pulsatile environment as ...
Selim Bozkurt
doaj +4 more sources
Ethical challenges with the left ventricular assist device as a destination therapy [PDF]
Philosophy, Ethics, and Humanities in Medicine, 2008The left ventricular assist device was originally designed to be surgically implanted as a bridge to transplantation for patients with chronic end-stage heart failure.
Rady Mohamed Y+3 more
doaj +4 more sources
A fully magnetically levitated left ventricular assist device — final report [PDF]
New England Journal of Medicine, 2019Background In two interim analyses of this trial, patients with advanced heart failure who were treated with a fully magnetically levitated centrifugal‐flow left ventricular assist device were less likely to have pump thrombosis or nondisabling stroke ...
Ewald, G.A., Itoh, A.
core +3 more sources
Pediatric Ventricular Assist Device [PDF]
Korean Circulation Journal, 2019There have been great advances in ventricular assist device (VAD) treatment for pediatric patients with advanced heart failure. VAD support provides more time for the patient in the heart transplant waiting list.
박영환, 박한기, 신유림
core +6 more sources
Epistaxis Rates and Health Care Utilization in Patients With a Ventricular Assist Device [PDF]
OTO OpenObjective Identify baseline epistaxis rates and epistaxis‐related health care utilization trends in the ventricular assist device (VAD) population.
Eric Rohe+4 more
doaj +2 more sources
Pulsatile Ventricular Assist Platform: A Novel Surgically Implanted Ventricular Assist Device. [PDF]
JACC Basic Transl SciBastos MB+5 more
europepmc +3 more sources
Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center [PDF]
The Korean Journal of Internal Medicine, 2022Background/Aims The continuous flow left ventricular assist device (cf-LVAD) has improved the survival of chronic end-stage heart failure (HF) patients.
Yoonjee Park+5 more
doaj +1 more source
JAMA Network Open, 2022
This cohort study assesses inequities in access and outcomes in the receipt of left ventricular assist device (LVAD) therapy for Black and female patients in the US.
T. Cascino+13 more
semanticscholar +1 more source
This cohort study assesses inequities in access and outcomes in the receipt of left ventricular assist device (LVAD) therapy for Black and female patients in the US.
T. Cascino+13 more
semanticscholar +1 more source
European Journal of Heart Failure, 2021
The MOMENTUM 3 pivotal trial established superiority of the HeartMate 3 (HM3) left ventricular assist device (LVAD), a fully magnetically levitated centrifugal‐flow pump, over the HeartMate II axial‐flow pump.
M. Mehra+10 more
semanticscholar +1 more source
The MOMENTUM 3 pivotal trial established superiority of the HeartMate 3 (HM3) left ventricular assist device (LVAD), a fully magnetically levitated centrifugal‐flow pump, over the HeartMate II axial‐flow pump.
M. Mehra+10 more
semanticscholar +1 more source
Ventricular assist devices [PDF]
Continuing Education in Anaesthesia Critical Care & Pain, 2012Heart failure occurs in 1% of the UK adult population yet represents 5% of all hospital admissions, according to the 2008/09 National Heart Failure audit (http://www.ic.nhs.uk/ webfiles/publications/002_Audits/NHS_IC_ HEART_FAILURE_AUDIT_13-12-10.pdf ).
Paul Harris, Lakshminarasimhan Kuppurao
openaire +3 more sources